tiprankstipranks
Advertisement
Advertisement
Biotron Cautions Investors on Risks in Forward-Looking Statements
PremiumCompany AnnouncementsBiotron Cautions Investors on Risks in Forward-Looking Statements
3M ago
Biotron Expands Hepatitis B Drug Potential and Advances Sedarex Integration
Premium
Company Announcements
Biotron Expands Hepatitis B Drug Potential and Advances Sedarex Integration
3M ago
Biotron Posts Wider Half-Year Loss Amid Zero Revenue and Raised Asset Backing
Premium
Company Announcements
Biotron Posts Wider Half-Year Loss Amid Zero Revenue and Raised Asset Backing
4M ago
Biotron Expands with Sedarex Acquisition and Reports Strong Preclinical HBV Drug Data
PremiumCompany AnnouncementsBiotron Expands with Sedarex Acquisition and Reports Strong Preclinical HBV Drug Data
5M ago
Biotron Directors Lift Holdings Through Rights Issue Participation
Premium
Company Announcements
Biotron Directors Lift Holdings Through Rights Issue Participation
6M ago
Biotron Seeks ASX Quotation for 181.7 Million New Options
Premium
Company Announcements
Biotron Seeks ASX Quotation for 181.7 Million New Options
6M ago
Biotron Discloses Top 20 Holders and Distribution of Newly Listed Options
PremiumCompany AnnouncementsBiotron Discloses Top 20 Holders and Distribution of Newly Listed Options
6M ago
Biotron Raises $645,861 via Rights Issue to Advance Hepatitis B Program
Premium
Company Announcements
Biotron Raises $645,861 via Rights Issue to Advance Hepatitis B Program
6M ago
Biotron Limited’s BITO Securities Suspended by ASX
Premium
Company Announcements
Biotron Limited’s BITO Securities Suspended by ASX
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100